Records containing: SARS-CoV-2 Infection

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2022-03-23
  Microvascular Injury With Secondary Edema, and Distal Peripheral Vascular Thrombosis Contribution to Clinical Deterioration of Non-critically Ill Patients Hospitalized for SARS-CoV-2 Pneumonia Without Evidence of Pulmonary Embolism: a Preliminary Prospective Observational Study
• CLINICAL_TRIALS study record update · 2022-03-18
  A Pilot, Randomized, Placebo-Controlled Trial of GC4419 (Avasopasem Manganese) in Patients With Critical Illness Due to SARS-CoV-2 Infection (COVID-19)
• CLINICAL_TRIALS study record update · 2022-03-14
  A Prospective Household Study of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus Community Burden, Transmission Dynamics and Viral Interaction in South Africa (the PHIRST-C Study)
• CLINICAL_TRIALS study record update · 2022-03-02
  Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on the Basic Immunity of Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above
• CLINICAL_TRIALS study record update · 2022-03-02
  A Randomized, Double-blind, Positive-controlled Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C (A Bivalent SARS-CoV-2 Trimeric Spike Protein Vaccine) in Population Aged ≥18 Years Previously Fully Vaccinated With Either Inactivated or mRNA COVID-19 Vaccine or Previously Diagnosed With COVID-19
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2022-02-25
  A Randomized, Double Blind, Placebo Controlled, Combined Phase 1/2 Single Dose and Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of NGM621 in Healthy Volunteers and the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy in Subjects With Confirmed SARS-CoV-2 Infection
• CLINICAL_TRIALS study record update · 2022-02-17
  A Phase 2A/B, Randomized, Observer-blinded, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity, and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in South African Adult Subjects Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV
• CLINICAL_TRIALS study record update · 2022-02-10
  Reconvalescent Plasma / Camostat Mesylate Early in Sars-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
• CLINICAL_TRIALS study record update · 2022-02-07
  Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection
• CLINICAL_TRIALS study record update · 2022-02-07
  A Randomized Open Label Phase-II Clinical Trial With or Without Infusion of Plasma From Subjects After Convalescence of SARS-CoV-2 Infection in High-Risk Patients With Confirmed Severe SARS-CoV-2 Disease
• CLINICAL_TRIALS study record update · 2022-01-25
  A Randomized, Double-blinded, Placebo-controlled Phase I/II Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated Vaccine Against COVID-19.
• CLINICAL_TRIALS study record update · 2022-01-25
  A Randomized, Double-blinded, Placebo-controlled Phase I/II Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA Vaccine Against COVID-19.
• CLINICAL_TRIALS study record update · 2022-01-18
  Evaluation de la COagulopathie et de la Dysfonction enDOthéliale Comme Facteur prédictif de la gravité de l'Infection Par SARS-CoV-2 / COVID-19
• CLINICAL_TRIALS study record update · 2022-01-12
  Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Solid Organ Transplant Recipients
• CLINICAL_TRIALS study record update · 2021-12-29
  Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness
• CLINICAL_TRIALS study record update · 2021-12-21
  Validation of Specificity, Sensitivity, and Accuracy for an ELISpot-based In-vitro Diagnostic (IVD) Kit 'Corona-T-test' for Assessment of SARS-COV-2-specific T-cell Response
• CLINICAL_TRIALS study record update · 2021-12-17
  CovidSurg-3: Outcomes of Surgery in COVID-19 Infection
• CLINICAL_TRIALS study record update · 2021-12-15
  Measurement of Respiratory Aerosols in PCR SARS-CoV-2 Positive and Negative Children and Adults
• CLINICAL_TRIALS study record update · 2021-12-15
  Characterization of the Index Individual for Contact Participants Enrolled in Clinical Trials of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Prevention Interventions; COVID-19 Prevention Trials Network (CoVPN) 3502-01
• CLINICAL_TRIALS study record update · 2021-11-24
  COVID-19 VACCINE SAFETY AND EFFECTIVENESS
• CLINICAL_TRIALS study record update · 2021-11-16
  A Phase 1, Randomized, Double-blind, Placebo-controlled, Parallel Group, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects
• CLINICAL_TRIALS study record update · 2021-10-14
  Effect of COVID-19 Lockdown on Alcohol and Tobacco Use in Two Chilean Universities: a Difference-in-difference Analysis
• CLINICAL_TRIALS study record update · 2021-09-10
  Comparison of Two Types of Dialyzers (PMMA vs Polysulfone) on Cytokine Extraction in Hemodialysis Patients and COVID Infection. A Multicenter Prospective Study
• CLINICAL_TRIALS study record update · 2021-09-08
  Convalescent Methylene Blue Treated (MBT) Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients: a Randomized Double Blind Study (COnV-ert)
• CLINICAL_TRIALS study record update · 2021-08-27
  A Longitudinal, Non-randomized Study to Evaluate the Utility of the INanoBio's Protein Arrays in Detecting Unique Antibodies in COVID-19 Patients